According to WiseGuy Reports, the Erlotinib HCl Market generated USD 2,113.7 million in 2024 and expanded to USD 2,263.7 million in 2025. The market is forecast to reach USD 4,500.0 million by 2035, advancing at a CAGR of 7.1%. Rising cancer prevalence, growing demand for targeted oncology therapies, expanding patient awareness, increasing regulatory approvals, and continuous pharmaceutical...